Deep learning water-unsuppressed MRSI at ultra-high field for simultaneous quantitative metabolic, susceptibility and myelin water imaging
Abstract
Purpose: Magnetic Resonance Spectroscopic Imaging (MRSI) maps endogenous brain metabolism while suppressing the overwhelming water signal. Water-unsuppressed MRSI (wu-MRSI) allows simultaneous imaging of water and metabolites, but large water sidebands cause challenges for metabolic fitting. We developed an end-to-end deep-learning pipeline to overcome these challenges at ultra-high field. Methods:Fast high-resolution wu-MRSI was acquired at 7T with non-cartesian ECCENTRIC sampling and ultra-short echo time. A water and lipid removal network (WALINET+) was developed to remove lipids, water signal, and sidebands. MRSI reconstruction was performed by DeepER and a physics-informed network for metabolite fitting. Water signal was used for absolute metabolite quantification, quantitative susceptibility mapping (QSM), and myelin water fraction imaging (MWF). Results: WALINET+ provided the lowest NRMSE (< 2%) in simulations and in vivo the smallest bias (< 20%) and limits-of-agreement (+-63%) between wu-MRSI and ws-MRSI scans. Several metabolites such as creatine and glutamate showed higher SNR in wu-MRSI. QSM and MWF obtained from wu-MRSI and GRE showed good agreement with 0 ppm/5.5% bias and +-0.05 ppm/ +- 12.75% limits-of-agreement. Conclusion: High-quality metabolic, QSM, and MWF mapping of the human brain can be obtained simultaneously by ECCENTRIC wu-MRSI at 7T with 2 mm isotropic resolution in 12 min. WALINET+ robustly removes water sidebands while preserving metabolite…
Read the paper
Related studies
- Biportal endoscopic versus microscopic lumbar decompressive laminectomy in patients with spinal stenosis: A randomized controlled trial
- A whey protein-based multi-ingredient nutritional supplement stimulates gains in lean body mass and strength in healthy older men: A randomized controlled trial
- Supplement-based nutritional strategies to tackle frailty: A multifactorial, double-blind, randomized placebo-controlled trial
- A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression
- Creatine supplementation (3 g/day) and bone health in older women: a 2-year, randomized, placebo-controlled trial
- A Multi-Ingredient Nutritional Supplement in Combination With Resistance Exercise and High-Intensity Interval Training Improves Cognitive Function and Increases N-3 Index in Healthy Older Men: A Randomized Controlled Trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.